Metformin Improves Mitochondrial Respiratory Activity through Activation of AMPK

Cited by papers we hold 8

• Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease · 2023
  No notice
• Current and future therapeutic strategies for Alzheimer’s disease: an overview of drug development bottlenecks · 2023
  No notice
• Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales · 2022
  No notice
• Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms · 2022
  No notice
• AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice · 2021
  No notice
• A Critical Review of the Evidence That Metformin Is a Putative Anti-Aging Drug That Enhances Healthspan and Extends Lifespan · 2021
  No notice
• The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective · 2020
  No notice
• Molecular Mechanisms of Adipogenesis: The Anti-adipogenic Role of AMP-Activated Protein Kinase · 2020
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.